医学
无容量
易普利姆玛
肾细胞癌
舒尼替尼
内科学
肿瘤科
癌症
免疫疗法
作者
Robert J. Motzer,Nizar M. Tannir,Ray McDermott,Osvaldo Arén Frontera,Bohuslav Melichar,Toni K. Choueiri,Elizabeth R. Plimack,Philippe Barthélémy,Camillo Porta,Saby George,Thomas Powles,Frede Donskov,Victoria Neiman,Christian Kollmannsberger,Pamela Salman,Howard Gurney,Robert D. Hawkins,Alain Ravaud,Marc‐Oliver Grimm,Sergio Bracarda
标识
DOI：10.1056/nejmoa1712126
摘要
Nivolumab plus ipilimumab produced objective responses in patients with advanced renal-cell carcinoma in a pilot study. This phase 3 trial compared nivolumab plus ipilimumab with sunitinib for previously untreated clear-cell advanced renal-cell carcinoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
pluto
Rye227
冰魂
昏睡的蟠桃
bc
jenningseastera
归尘
乐乐
平常的毛豆
back you up
Auston_zhong
科研小民工
不倦
遇上就这样吧
今天只做一件事
顺心香菇
zmnzmnzmn
Cat
wy.he
皖公网安备34019202002308
